USPTO serial 99905394
MITO-RESUSCITATE
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAI, TINA HSIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MITO-RESUSCITATE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Syosset, NY, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Coenzyme Q10 dietary supplements; Dietary and nutritional supplements; Dietary and nutritional supplements containing Vitamin C, Vitamin D3, Vitamin B1, Vitamin B2, Nicotinic Acid, Vitamin B5, Vitamin B6, Methyl Folate, Vitamin B12, Biotin, Magnesium, Zinc, Selenium, Copper, Acetyl-L-Carnitine Hydrocholoride, Taurine, Tumeric, Luteolin, R-Alpha Lipoic Acid, Coenzyme Q10, Betaine Hydrocholoride, Vitamin E, Pyrroloquinoline Quinone, Lutein, Boron, Zeaxanthin, Vitamin K2; Dietary and nutritional supplements containing Acetyl-L-Carnitine, Betain Hydrocholoride, R-Alpha Lipoic Acid, Curcumin, Taurine, Luteolin, Coenzyme Q10, Pyrroloquinoline Quinone, Piperine, Boron, Glycinate, Copper, Bisglycinate; Dietary and nutritional supplements containing Lutein, Zeaxanthin, Magnesium, Bisglycinate, Selenium, Vitamin B1, Thiamine, Vitamin B2, Riboflavin, Vitamin B3, Nicotinic Acid, Vitamin B5, Panthothenate,Vitamin B6,Pyridoxine Hydrocholoride, Vitamin B7, Biotin, Vitamin B9, 5-MTHF, Methyl Folate, Vitamin B12, Methylcobalamin, Vitamin C Calcium Ascorbate; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements for targeted biological support to sustain normal mitochondrial function including Active B-Complex Vitamins, Bioavailable Zinc Picolinate, and Pure R-Alpha Lipoic Acid; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement beverage for targeted biological support to sustain normal mitochondrial function including Active B-Complex Vitamins, Bioavailable Zinc Picolinate, and Pure R-Alpha Lipoic Acid; Dietary supplement drink mixes; Dietary supplements; Dietary supplements consisting primarily of Nicotinic Acid; Dietary supplements for animals; Dietary supplements for controlling cholesterol; Dietary supplements for human beings; Dietary supplements for human consumption; Dietary supplements for humans; Dietary supplements for humans and animals; Dietary supplements for targeted biological support to sustain normal mitochondrial function including Active B-Complex Vitamins, Bioavailable Zinc Picolinate, and Pure R-alpha Lipoic Acid; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for urinary health; Lutein dietary supplements; Natural dietary supplements; Nutritional and dietary supplements formed and packaged as bars; Vitamins and dietary food supplements for animals | ACTIVE | May 10, 2026 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 6, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 6, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 6, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 25, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 25, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 25, 2026 | NWAP | NEW APPLICATION ENTERED | — |